泰和新材(002254.SZ):擬以1000萬元參設煙台國豐中泰芝財股權投資基金
格隆匯7月27日丨泰和新材(002254.SZ)公佈,為拓展盈利渠道、增加投資收益,公司擬以自有資金人民幣1000萬元與中泰資本股權投資管理(深圳)有限公司(“中泰資本”)、 煙台同聚私募(投資)基金管理有限責任公司(“煙台同聚”)、煙台國泰誠豐資產管理有限公司(“國泰誠豐”)、 煙台芝罘財金控股集團有限公司(“財金控股”)共同出資設立煙台國豐中泰芝財股權投資基金合夥企業(有限合夥)(暫定名,具體以市場監督管理部門核准的名稱為準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.